上海医药:下属公司产品获得菲律宾药品注册证书

每日经济新闻
Aug 22

每经AI快讯,8月22日,上海医药(601607.SH)公告称,公司生产的缩宫素注射液及醋酸奥曲肽注射液收到菲律宾食品药品监督管理局颁发的药品注册证书,获得批准上市。缩宫素注射液主要用于引产、催产等;醋酸奥曲肽注射液主要用于治疗肢端肥大症等。公司在菲律宾的上市未投入额外研发费用,仅注册相关费用约人民币5万元。该药品获得注册批文,标志着公司具备了在菲律宾市场销售该药品的资格,对公司拓展海外市场带来...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10